AXGN (Axogen, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by AXGN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | JOSEPH A. TYNDALL | Director | Sell | — | — |
| 2026-08-12 | Marc A Began | EVP & General Counsel | MIXED | — | — |
| 2026-08-12 | Amy McBride Wendell | Director | MIXED | — | — |
| 2026-08-11 | Kathy Johnson Weiler | Director | Sell | — | — |
| 2026-06-26 | Kathy Johnson Weiler | Director | A | — | — |
| 2026-06-26 | JOHN JOHNSON | Director | A | — | — |
| 2026-06-26 | Alan M Levine | Director | A | — | — |
| 2026-06-26 | Amy McBride Wendell | Director | A | — | — |
| 2026-06-26 | JOSEPH A. TYNDALL | Director | A | — | — |
| 2026-06-26 | William P. Mr. Burke | Director | A | — | — |
| 2026-06-26 | PAUL THOMAS | Director | A | — | — |
| 2026-06-23 | JOHN JOHNSON | Director | M | — | — |
| 2026-06-23 | JOSEPH A. TYNDALL | Director | M | — | — |
| 2026-06-23 | PAUL THOMAS | Director | M | — | — |
| 2026-06-23 | William P. Mr. Burke | Director | M | — | — |
| 2026-06-23 | Alan M Levine | Director | M | — | — |
| 2026-06-23 | Kathy Johnson Weiler | Director | M | — | — |
| 2026-06-23 | Amy McBride Wendell | Director | M | — | — |
| 2026-05-12 | Amy McBride Wendell | Director | MIXED | — | — |
| 2026-05-08 | Jens Kemp | Chief Marketing Officer | Sell | — | — |
| 2026-05-08 | Doris Quackenbush | Sales VP | Sell | — | — |
| 2026-05-08 | JOHN JOHNSON | Director | MIXED | — | — |
| 2026-05-08 | Kathy Johnson Weiler | Director | MIXED | — | — |
| 2026-05-08 | Lindsey Marie Hartley | CFO | MIXED | — | — |
| 2026-03-18 | Erick Wayne DeVinney | Chief Innovation Officer | MIXED | — | — |
| 2026-03-18 | Lindsey Marie Hartley | CFO | MIXED | — | — |
| 2026-03-02 | Erick Wayne DeVinney | Chief Innovation Officer | MIXED | — | — |
| 2026-03-02 | Jens Kemp | Chief Marketing Officer | MIXED | — | — |
| 2026-03-02 | Marc A Began | EVP & General Counsel | MIXED | — | — |
| 2026-02-27 | MICHAEL D DALE | Chief Executive Officer | A | — | — |
| 2026-02-27 | Lindsey Marie Hartley | CFO | MIXED | — | — |
| 2026-02-24 | Lindsey Marie Hartley | CFO | MIXED | — | — |
| 2025-12-17 | Amy McBride Wendell | Director | MIXED | — | — |
| 2025-12-17 | Lindsey Marie Hartley | CFO | MIXED | — | — |
| 2025-12-17 | Kathy Johnson Weiler | Director | MIXED | — | — |
| 2025-12-12 | MICHAEL D DALE | Chief Executive Officer | Sell | — | — |
| 2025-12-12 | Marc A Began | EVP & General Counsel | Sell | — | — |
| 2025-12-10 | PAUL THOMAS | Director | Sell | — | — |
| 2025-12-10 | Lindsey Marie Hartley | CFO | MIXED | — | — |
| 2025-12-10 | Jens Kemp | Chief Marketing Officer | Sell | — | — |
| 2025-12-10 | JOHN JOHNSON | Director | MIXED | — | — |
| 2025-12-10 | JOSEPH A. TYNDALL | Director | MIXED | — | — |
| 2025-12-10 | Marc A Began | EVP & General Counsel | Sell | — | — |
| 2025-12-10 | Erick Wayne DeVinney | Chief Innovation Officer | Sell | — | — |
| 2025-12-10 | MICHAEL D DALE | Chief Executive Officer | Sell | — | — |
| 2025-12-05 | Marc A Began | EVP & General Counsel | A | — | — |
| 2025-12-05 | MICHAEL D DALE | Chief Executive Officer | A | — | — |
| 2025-12-05 | Jens Kemp | Chief Marketing Officer | A | — | — |
| 2025-12-05 | Erick Wayne DeVinney | Chief Innovation Officer | A | — | — |
| 2025-11-13 | William P. Mr. Burke | Director | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 3,711,111 | — |
| — | Director | 3,457,854 | — |
| — | 10%+ Owner | 3,381,439 | — |
| — | 10%+ Owner | 3,102,136 | — |
| — | 10%+ Owner | 3,000,000 | — |
| — | Director | 1,276,773 | — |
| — | CEO | 1,143,788 | — |
| — | Director | 601,741 | — |
| — | Director | 283,498 | — |
| — | Chief Innovation Officer | 262,781 | — |
| — | CFO | 260,868 | — |
| — | Director | 214,094 | — |
| — | Director | 121,329 | — |
| — | VP | 98,425 | — |
| — | Sales VP | 92,416 | — |
| — | SVP Sales | 88,057 | — |
| — | EVP & Chief Financial Officer | 74,693 | — |
| — | Chief Marketing Officer | 72,451 | — |
| — | Chief Executive Officer | 63,537 | — |
| — | CFO | 63,234 | — |
| — | Chief R&D Officer | 57,994 | — |
| — | Director | 50,893 | — |
| — | EVP & General Counsel | 50,135 | — |
| — | Director | 48,183 | — |
| — | VP Operations | 37,992 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AXGN quote page; the site-wide leaderboard is on the insider transactions hub.